Credit Suisse Conference | INSM Message Board Posts

Insmed Incorporated

  INSM website

INSM   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  48589 of 53832  at  11/12/2019 4:04:16 PM  by

BlaseDP31


Credit Suisse Conference

If you listen to the call from this morning, You find that Lewis is quite bullish and excited about 2020/2021. He expects approval in EU and Japan in the future, as the Key Opinion leaders and government in Japan are looking favorably on Arikayce to help the citizens. Lewis said with new guidelines coming out it would help everyone to know the protocols of determining and treating NTM in the future, which would help Arikayce if they were included. He mentioned that Insmed's drug launch ranked in the Top 10 of all orphan drug launched in the US. He thought the first year was outstanding and all positive, but they are looking to go global and are quite hopeful for frontline therapy going forward.
It is on Insmed's website.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 4     Views: 222
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
48590 Re: Credit Suisse Conference JAD9000 0 11/12/2019 5:55:11 PM






Financial Market Data provided by
.
Loading...